COVID-19 vaccine reduces allergic reactions in children with dermatitis, according to ACAAI study. Vaccinated children experience fewer respiratory and skin infections.
CStone Pharmaceuticals will present CS2015, an OX40L/TSLP bispecific antibody, at the 2025 ACAAI Annual Scientific Meeting, showcasing its potential for treating type 2 inflammation diseases.
ARS Pharma to present intranasal epinephrine data at ACAAI
ARS Pharma will present real-world data on intranasal epinephrine at the 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.